IDEAS home Printed from https://ideas.repec.org/a/zib/zbnmsp/v1y2017i1p27-32.html
   My bibliography  Save this article

A review of Anti-bacterial activity of Nigella sativa in gut of broiler chicks

Author

Listed:
  • Munazza shareef

    (Institute of Pharmacy, Physiology & Pharmacology,University of Agriculture, 38040 Faisalabad, Pakistan)

  • Muhammad Jamal

    (Institute of Pharmacy, Physiology & Pharmacology,University of Agriculture, 38040 Faisalabad, Pakistan)

  • Maliha sarfraz

    (Institute of Pharmacy, Physiology & Pharmacology,University of Agriculture, 38040 Faisalabad, Pakistan)

Abstract

Nigella sativa (N. sativa) is an important herb with multiple pharmacological activities. Therapeutic properties of N. sativa based on the availability of thymoquinone (TQ) which is an essential oil and an active chemical component. This review concerns about the anti-bacterial activity of N. sativa in the gut of broiler chicks. The addition of N. sativa powder appeared to have a positive impact on growth performance of broiler chicks as it improved body weight gain and feed conversion ratio (FCR) of broilers at finisher phase and it could be considered as a substitute of antibiotic growth promoter (lincomycin) for broiler chicks. It also affect the immune titer of Infectious Bursal Disease and New Castle Disease in the broiler chicks.

Suggested Citation

  • Munazza shareef & Muhammad Jamal & Maliha sarfraz, 2017. "A review of Anti-bacterial activity of Nigella sativa in gut of broiler chicks," Matrix Science Pharma (MSP), Zibeline International Publishing, vol. 1(1), pages 27-32, February.
    • Handle: RePEc:zib:zbnmsp:v:1:y:2017:i:1:p:27-32
    DOI: 10.26480/msp.01.2017.27.32
    as

    Download full text from publisher

    File URL: https://matrixscpharma.com/download/712/
    Download Restriction: no
    File URL: https://libkey.io/10.26480/msp.01.2017.27.32?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zib:zbnmsp:v:1:y:2017:i:1:p:27-32. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Zibeline International Publishing (email available below). General contact details of provider: https://matrixscpharma.com/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.